Table I.
Groups | Rat no. | Blood sugar level at 1 week, mmol/l | Blood sugar level at 3 weeks, mmol/la |
---|---|---|---|
Control | 1 | 7.2 | 5.4 |
2 | 7.9 | 6.8 | |
3 | 5.8 | 6.0 | |
4 | 6.0 | 7.9 | |
5 | 6.7 | 8.2 | |
6 | 6.4 | 5.8 | |
DM | 7 | 25.3 | 33.2 |
8 | 22.7 | 33.2 | |
9 | 21.6 | 33.1 | |
10 | 22.6 | HI | |
11 | 23.6 | 32.3 | |
12 | 20.8 | HI | |
DM + A | 13 | 20.0 | HI |
14 | 25.0 | HI | |
15 | 21.0 | HI | |
16 | 27.1 | HI | |
17 | 26.0 | 27.5 | |
18 | 25.6 | 29.4 | |
DM + B | 19 | 20.7 | HI |
20 | 28.7 | HI | |
21 | 23.7 | HI | |
22 | 29.6 | HI | |
23 | 24.9 | HI | |
24 | 26.9 | 31.1 |
HI indicates that the level was too high and exceeded the measurement range. DM, diabetes mellitus model; DM + A, diabetic rats treated with 5 µg/kg prucalopride; DM + B, diabetic rats treated with 10 µg/kg prucalopride.